LIÊN KẾT WEBSITE
Antioxidant and acetylcholinesterase inhibitory activities in vitro of different fraction of Huperzia squarrosa (Forst.) Trevis extract and attenuation of scopolamine-induced cognitive impairment in mice
Journal of Ethnopharmacology Số , năm 2017 (Tập 198, trang 24-32)
ISSN: 3788741
ISSN: 3788741
DOI: 10.1016/j.jep.2016.12.037
Tài liệu thuộc danh mục: Scopus
Article
English
Từ khóa: acetylcholine; antioxidant; cholinesterase inhibitor; glutathione peroxidase; Huperzia squarrosa extract; malonaldehyde; neuroprotective agent; plant extract; scopolamine; superoxide dismutase; thiol group; unclassified drug; antioxidant; cholinesterase inhibitor; neuroprotective agent; plant extract; scopolamine bromide; acetylcholine brain level; animal behavior; animal experiment; animal model; animal tissue; antioxidant activity; Article; attenuation; brain tissue; controlled study; DPPH radical scavenging assay; drug isolation; enzyme activity; enzyme blood level; enzyme inhibition; escape behavior; Huperzia; Huperzia squarrosa; IC50; in vitro study; in vivo study; inhibition kinetics; latent period; lipid peroxidation; male; memory; Morris water maze test; mouse; neuroprotection; nonhuman; oxidative stress; scopolamine-induced cognitive defect; swimming; animal; C57BL mouse; chemically induced; Cognitive Dysfunction; drug effects; maze test; Animals; Antioxidants; Cholinesterase Inhibitors; Cognitive Dysfunction; Huperzia; Lipid Peroxidation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Plant Extracts; Scopolamine Hydrobromide
Tóm tắt tiếng anh
Ethnopharmacological relevance Huperzia squarrosa (Forst.) Trevis is used in traditional medicine for improving memory deficits. Alkaloids, triterpenoids, flavonoids are main bioactive compounds of Huperzia squarrosa (Forst.) Trevis. Aim of the study This study aimed to investigate the antioxidant, AChE inhibitory activities in vitro of differents fraction of Huperzia squarrosa (Forst.) Trevis extract and neuroprotective effects of EtOAc fraction on scopolamine-induced cognitive impairment in mice. Materials and methods Antioxidant activity was measured by DPPH assay. AChE inhibitory effect in vitro and detail kinetic inhibition mechanism was evaluated by Ellman's assay. For in vivo assay, mice were administrated orally EtOAc fraction (150 and 300 mg/kg) for fourteen days, and injected scopolamine at a dose of 1 mg/kg intraperitoneally for four days to induce memory injured. The memory behaviors were evaluated using the Morris water maze. ACh levels were measured in brain tissue. Superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, malondialdehyde and protein thiol groups were also evaluated in the brains. Results Our data also demonstrated that EtOAc fraction had the strongest antioxidant with an IC50 value of 9.35±1.68 µg/mL and AChE inhibitory activity with an IC50 value of 23.44±3.14 μg/mL in a concentration-dependent manner. Kinetic inhibition analysis indicated that EtOAc fraction was mixed inhibition type with Ki (representing the affinity of the enzyme and inhibitor) was 34.75±1.42 µg/mL. Scopolamine significantly increased the escape latency time, reduced the crossings number, and swimming time in the target quadrant, while EtOAc fraction reversed these scopolamine-induced effects. EtOAc fraction significantly increased levels of acetylcholine in the brain. EtOAc fraction also significantly decreased oxidative stress in mice. Conclusion Our data suggest that EtOAc fraction of Huperzia squarrosa extract exhibited a strong neuroprotective effect on cognitive impairment, and may be a potential candidate for the treatment of Alzheimer. © 2016 Elsevier Ireland Ltd
